<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001223</url>
  </required_header>
  <id_info>
    <org_study_id>870029</org_study_id>
    <secondary_id>87-DK-0029</secondary_id>
    <nct_id>NCT00001223</nct_id>
  </id_info>
  <brief_title>Diagnosis and Treatment of Patients With Cystic Fibrosis</brief_title>
  <official_title>Diagnosis and Treatment of Patients With Cystic Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of&#xD;
      the study is to obtain samples and data collected during standard clinical care for future&#xD;
      research to expand knowledge of the natural history, clinical manifestations (phenotypes) and&#xD;
      the genetic variants (genotypes) of cystic fibrosis....&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of&#xD;
      the study is to obtain samples and data collected during standard clinical care for future&#xD;
      research to expand knowledge of the natural history, clinical manifestations (phenotypes) and&#xD;
      the genetic variants (genotypes) of cystic fibrosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 1988</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To develop a database and collection of samples obtained from patients with CF during their clinical care to allow for future research</measure>
    <time_frame>end of study</time_frame>
    <description>To develop a collection of samples and a database from patients with cystic fibrosis to be used in future research.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">9999</enrollment>
  <condition>Cystic Fibrosis</condition>
  <condition>Liver Disease or Abnormalities</condition>
  <condition>Diabetes</condition>
  <condition>Pancreatic Insufficiency (Exocrine and Endocrine)</condition>
  <arm_group>
    <arm_group_label>CF Patients</arm_group_label>
    <description>cystic fibrosis patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CF Relatives</arm_group_label>
    <description>relatives of cystic fibrosis patients</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Primarily local population but also any adult patient/relative that moves into the area,&#xD;
        either through CF Foundation or relocating for personal reasons.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA&#xD;
&#xD;
          -  Patients with known or suspected CF and family members of patients with CF.&#xD;
&#xD;
          -  &gt;=4 years of age&#xD;
&#xD;
        EXCLUSION CRITERIA&#xD;
&#xD;
        -Concomitant medical, psychiatric or other problems which might complicate interpretation&#xD;
        of studies of CF, or for which we are unable to provide adequate care.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Milica S Chernick, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Milica S Chernick, M.D.</last_name>
    <phone>(301) 496-3434</phone>
    <email>milicac@bdg10.niddk.nih.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_1987-DK-0029.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <verification_date>January 21, 2023</verification_date>
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>November 3, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 1999</study_first_posted>
  <last_update_submitted>January 25, 2023</last_update_submitted>
  <last_update_submitted_qc>January 25, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cystic Fibrosis</keyword>
  <keyword>Pancreatic Insufficiency</keyword>
  <keyword>Bronchiectasis</keyword>
  <keyword>Liver Disease</keyword>
  <keyword>Natural History</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>.We are open to sharing IPD if requested, but it has not as-to-date been requested from this protocol.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

